INTRODUCTION
Intravenous to oral switch in clinically stable patients is associated with lower costs and reduced duration of hospital stay. For many drugs, bioavailability for intravenous and oral route is comparable. Oral Route is associated with better compliance, lower administration and patient related cost in most of the cases 1 . Use of intravenous paracetamol is quite common in tertiary care hospitals across the country. It is primarily used for short term treatment of moderate to severe pain after surgery or in case of fever. However oral paracetamol is as effective as the IV preparation, and is a cost effective choice. 2 
METHODOLOGY
IV paracetamol provides onset of pain relief in 5-10 minutes. Due to 100% bioavailability, chances of toxicity are higher as well. Oral paracetamol is absorbed completely and achieves peak plasma concentration 30-60miuntes after administration. 3 
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•Obvious impairment/ inability to absorb orally administered paracetamol • Significant/ prolonged vomiting (and/or nausea) secondary to e.g. post-operative nausea and vomiting / postoperative ileus/ bowel obstruction/ short bowel syndrome Cautions for the use of IV paracetamol 4
•Hepatocellular insufficiency.
•Severe renal insufficiency (creatinine clearance ≤ 15ml/min).
•Chronic malnutrition (low reserves of hepatic glutathione).
• Dehydration.
• Concomitant use of paracetamol (4 g per day for at least 4 days) with oral anticoagulants may lead to slight variations of INR values. In this case, increased monitoring of INR values should be conducted during the period of concomitant use as well as for 1 week after paracetamol treatment has been discontinued.
MHRA issued an alert in 2010 regarding accidental over-dose of paracetamol and chances of life threatening hepatotoxicity. 5 Intravenous paracetamol orders are being intervened by pharmacists at SKMCH&RC wherever appropriate for switching to oral route. In this context an online restriction for IV paracetamol orders was implemented in Jun, 2014. Physicians need to identify the reason for choosing intravenous root for paracetamol administration for continuing the order. This restriction, in addition to interventions by the pharmacists, is expected to improve IV to PO switch culture at the institute. In order to evaluate the impact of restriction and online interventions on the trend of injection use, we conducted a retrospective analysis of IV paracetamol orders for the year 2014. Consumption ofparacetamol injections month wise as well as quarter wise was compared against guidelines devised for IV paracetamol use.
Methods:
It was a retrospective cross-sectional study. Paracetamol injection use was evaluated for the year 2014. Data was collected using hospital information system (HIS). Data was collected for four respective quarters and compared to identify the trend of paracetamolinjection use. Restriction on IVparacetamol use was implemented using HIS restriction form. 
RESULTS:

DISCUSSION:
Intravenous route is generally recommended for patients where oral route is intolerable. However, it is a costly alternative to oral route. The aim of monitoring drug therapy is to minimize the duration of intravenous medication use and switching to the oral dosage form as soon as clinically feasible. This improves compliance and reduces cost for the patient as well as the service facility. Furthermore, intravenous administration is associated with higher risk of infusion reactions and medical management cost.
Institutes develop in-house techniques to improve effective and timely IV to per oral (PO) switch for medications. Proper medication reconciliation is highly recommended for this purpose. SKMCH&RC implemented online IV paracetamol restriction in Jun, 2014 to improve the appropriateness of IV paracetamol use. We carried out a retrospective coss-sectional analysis for evaluating the impact of restriction. It was observed that the number of paracetamol injections used before implementation of restriction was 11429 from Jan to May, 2014. After implementation of restriction, the number reduced to 8219 in total from Jun, 2014 to Dec, 2014. There was 28.1% decrease in the use of paracetamol injectable dosage form after implementation of the restriction. In the month wise break-up of injection consumption, it was observed that 2115 injections were consumed in Jan 
CONCLUSION:
IV to PO switch of paracetamol through online restrictionis associated with reduced parenteral paracetamol prescribing and lower cost of therapy.
